SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Satellos Bioscience Inc. (MSLE) News

Follow Satellos Bioscience Inc. (MSLE) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 8 public stories across 8 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol MSLE Asset equity Sector Markets 90 days 5 Last 7.425 Updated Sep 24, 2026, 11:00 AM UTC Open live news feed Open MSLE chart & news
L MSLE - Satellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy (FSHD) and a Partnership with FSHD Canada Foundation Providing Non-Dilutive Financing to Support Clinical Development MSLE - Satellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy (FSHD) and a Partnership with FSHD Canada Foundation Providing Non-Dilutive Financing to Support Clinic REGULATION | Sep 24, 2026, 11:00 AM UTC H MSLE - Satellos to Present at the 31st Annual Congress of the World Muscle Society MSLE - Satellos to Present at the 31st Annual Congress of the World Muscle Society GEOPOLITICS | Sep 15, 2026, 11:00 AM UTC L MSLE: Satellos names Forazapadin as INN for lead candidate SAT-3247 Satellos announced Forazapadin has been assigned as the international nonproprietary name for lead drug candidate SAT-3247. EQUITY | Sep 09, 2026, 11:00 AM UTC L MSLE - Satellos to Participate in Upcoming Investor Conferences MSLE - Satellos to Participate in Upcoming Investor Conferences EQUITY | Sep 01, 2026, 11:01 AM UTC L Satellos (MSLE) reports second-quarter 2026 financial results Satellos (MSLE) reports its second quarter of 2026 financial results and highlights its company progress, with no additional figures included in the provided alert. EARNINGS | Aug 13, 2026, 09:02 PM UTC M Multiple Companies Announce Public Offerings Several companies announce public offerings and private placements of various securities EQUITY | Aug 12, 2026, 09:25 AM UTC L MSLE Files Mixed Shelf For $300M MSLE files Form F-10 for $300,000,000 mixed shelf MNA | Aug 11, 2026, 08:10 PM UTC L MSLE Presents Updates MSLE's Satellos to present clinical program updates at ICNMD 2026 EARNINGS | Jun 25, 2026, 11:00 AM UTC